FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 28 and 6 polymorphism: a multicenter, retrospective study.

Umemoto K, Takahashi H, Morizane C, Yamada I, Shimizu S, Shioji K, Yoshida Y, Motoya M, Mizuno N, Kojima Y, Terashima T, Uesugi K, Ueno M, Furuse J, Akimoto T, Ikeda M

Open source

DOI: 10.1007/s00280-020-04206-w
Published: 2021 Mar
Container: Cancer chemotherapy and pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00280-020-04206-w,
  title = {FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study.},
  author = {Umemoto K and Takahashi H and Morizane C and Yamada I and Shimizu S and Shioji K and Yoshida Y and Motoya M and Mizuno N and Kojima Y and Terashima T and Uesugi K and Ueno M and Furuse J and Akimoto T and Ikeda M},
  year = {2021},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-020-04206-w},
  url = {https://doi.org/10.1007/s00280-020-04206-w}
}

RIS

TY  - JOUR
TI  - FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study.
AU  - Umemoto K
AU  - Takahashi H
AU  - Morizane C
AU  - Yamada I
AU  - Shimizu S
AU  - Shioji K
AU  - Yoshida Y
AU  - Motoya M
AU  - Mizuno N
AU  - Kojima Y
AU  - Terashima T
AU  - Uesugi K
AU  - Ueno M
AU  - Furuse J
AU  - Akimoto T
AU  - Ikeda M
PY  - 2021
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-020-04206-w
UR  - https://doi.org/10.1007/s00280-020-04206-w
ER  -

APA

K, U., H, T., C, M., I, Y., S, S., K, S., Y, Y., M, M., N, M., Y, K., T, T., K, U., M, U., J, F., T, A., & M, I. (2021). FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-020-04206-w

Source records

pubmed · retrieved 2026-09-26T09:41:04.051Z
europe-pmc · retrieved 2026-09-26T09:41:04.048Z